Witnessing the stock’s movement on the chart, on Thursday, Theriva Biologics Inc (AMEX: TOVX) set off with pace as it heaved 4.64% to $0.45, before settling in for the price of $0.43 at the close. Taking a more long-term approach, TOVX posted a 52-week range of $0.40-$7.15.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 39.99%. Meanwhile, its Annual Earning per share during the time was 39.99%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 79.72%. This publicly-traded company’s shares outstanding now amounts to $9.06 million, simultaneously with a float of $8.96 million. The organization now has a market capitalization sitting at $4.04 million. At the time of writing, stock’s 50-day Moving Average stood at $0.4636, while the 200-day Moving Average is $1.1283.
Theriva Biologics Inc (TOVX) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Theriva Biologics Inc’s current insider ownership accounts for 1.04%, in contrast to 2.10% institutional ownership.
Theriva Biologics Inc (TOVX) Earnings and Revenue Records
Theriva Biologics Inc’s EPS increase for this current 12-month fiscal period is 79.72% and is forecasted to reach -5.78 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 36.86% through the next 5 years, which can be compared against the 39.99% growth it accomplished over the previous five years trading on the market.
Theriva Biologics Inc (AMEX: TOVX) Trading Performance Indicators
Let’s observe the current performance indicators for Theriva Biologics Inc (TOVX). It’s Quick Ratio in the last reported quarter now stands at 1.53.
In the same vein, TOVX’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -20.68, a figure that is expected to reach -0.78 in the next quarter, and analysts are predicting that it will be -5.78 at the market close of one year from today.
Technical Analysis of Theriva Biologics Inc (TOVX)
Going through the that latest performance of [Theriva Biologics Inc, TOVX]. Its last 5-days volume of 0.7 million was inferior to the volume of 0.71 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 12.41% While, its Average True Range was 40.94%.
Raw Stochastic average of Theriva Biologics Inc (TOVX) in the period of the previous 100 days is set at 4.03%, which indicates a major fall in contrast to 26.58% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0362 that was lower than 0.0748 volatility it exhibited in the past 100-days period.
